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After presenting for a routine screening exam, and 57-year-old man was diagnosed with an incidentaloma—a primitive
neuroectodermal tumor (PNET) of the thymus. A member of the Ewing sarcoma family of tumors, a PNET is typically regarded
as a malignancy of childhood and adolescence, usually occurring in the central nervous system. In the case at hand, our patient
had an extremely unusual presentation, given his age and tumor location. Initial presentation is the only predictor for long-term
survival. Current treatment recommendations advocate complete surgical resection whenever possible, radiation therapy, and
adjuvant versus neoadjuvant chemotherapy.
A 57-year-old man presented for routine EGD as fol-
lowup for his Barrett’s esophagus, and upon complaining of
palpitations, was referred to the Emergency Department. An
EKG revealed new-onset atrial ﬁbrillation. On subsequent
workup, a nuclear stress test was performed, but the study
was deemed limited given the marked amount of radioactive
uptake in the upper thorax. Suspicious for a mass lesion, a
CT of the chest was performed. A heterogeneously enhanc-
ing anterior mediastinal mass was found, with diﬀerential
diagnosis including thymic carcinoma, germ cell tumor,
or lipoma. An ultrasound-guided biopsy was performed,
which revealed a trabecular neoplasm highly suggestive of
neuroendocrine tumor. PET tumor imaging showed the
anterior mediastinal mass to have intense FDG activity,
which in correlation with the pathology report, favored
thymic carcinoma. There was no evidence of lymph node
or distant metastases. The surgical service was consulted
for tumor debulking, and a sternotomy with mediastinal
exploration was planned. The tumor was very vascular.
It extended into the right pleural space, and even deep
into the left pleural cavity, going up to the thoracic inlet.
The posteroinferior aspect of the tumor was overlying the
great vessels. The tumor was inﬁltrating the innominate
vein and left phrenic nerve. Due to tumor extent and in-
ﬁltration into surrounding structures, extensive surgical re-
section or thymectomy was abandoned. Surgical pathology
showed a malignant neuroendocrine tumor histologically
and immunophenotypically consistent with a peripheral
primitive neuroectodermal tumor.
Primitive neuroectodermal tumor (PNET), a member of
the Ewing sarcoma family of tumors (ESFTs), is typically
regarded as a malignancy of childhood and adolescence,
usually occurring in the central nervous system. Although
rare, so-called peripheral PNETs do exist, usually found in
the deep soft tissues of the trunk and lower limbs. In the case
at hand, our patient had an extremely unusual presentation,
given his age, tumor location, and presentation (incidental
after cardiology workup). A systematic review reveals the
presented case to be only the second case of documented
thymic PNET in the English literature [1].
Pathologically,theESFTsareclassicallydescribedassmall
round blue cell tumors of neural crest derivation with diﬀer-
entiation along a neuroendocrine lineage [2].
Pathology reports for our patient’s tumor revealed the
followingimmunochemistry:positiveforCD99,cytokeratin,
CD57, and NSE; negative for TTF-1, CK7/CK20, CD56, syn-2 Case Reports in Medicine
Figure 1: CT scan of the chest revealing a large heterogenous mass
in the anterior mediastinum.
Figure 2: Pathology slide revealing a CD99+ poorly diﬀerentiated
trabecular neoplasm consistent with a neuroendocrine tumor.
aptophysin, chromogranin, CD117, PLAP, S100, CD30,
AFP, and CD1a. Histology revealed a poorly diﬀerentiated
trabecular neoplasm highly suggestive of a peripheral neu-
roectodermal tumor (Figure 1).
Radiographically, PNET imaging is nonspeciﬁc, with
use (of CT or MRI) aiding primarily in deﬁning tumor
scope, treatment strategy, and the evaluation of therapeutic
outcomes [3]. The appearance of tumor heterogeneity on
imaging represents areas of hemorrhage and necrosis, as was
the case in our patient’s large lesion (Figure 2)[ 4].
Initial presentation is the only predictor for long-term
survival, with primary tumor-only presentation having a 5-
year survival rate of 60%, compared to 33% for primary plus
metastatic disease [2, 5]. Overall survival rates in adults are
in line with pediatric study outcomes [6].
Current treatment recommendations advocate complete
surgical resection whenever possible, radiation therapy, and
adjuvant versus neoadjuvant chemotherapy. In the pediatric
population, treatment for PNET typically lasts 6–9 months
and consists of alternating courses of 2 chemotherapeutic
regimens: (1) vincristine, doxorubicin, and cyclophospham-
ideand(2)ifosfamideandetoposide.Treatmentissimilarfor
adults [7].
Our patient was scheduled for concurrent chemoradia-
tion with curative intent. Outcome was optimistic, and an
uncomplicated treatment course was carried out.
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